IL223298B
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups, compositions comprising the same and uses thereof
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
57 members in 12 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 34978310 | United States of America | P | |
| 36187810 | United States of America | P | |
| 38642810 | United States of America | P | |
| 2011038459 | United States of America | W |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| CA2799501A1 | Canada | A1 | |
| WO2011150408A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW201202262A | Taiwan Province of China | A | |
| WO2011150408A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2012065169A1 | United States of America | A1 | |
| AU2011257980A1 | Australia | A1 | |
| IL223298A0 | Israel | A0 | |
| IL223298D0 | Israel | D0 | |
| CN103003288A | China | A | |
| EP2576574A2 | European Patent Office (EPO) | A2 | |
| AU2013202731A1 | Australia | A1 | |
| JP2013530154A | Japan | A | |
| KR20130118227A | Republic of Korea | A | |
| US8779128B2 | United States of America | B2 | |
| US2015073140A1 | United States of America | A1 | |
| NZ603606A | New Zealand | A | |
| JP2016000059A | Japan | A | |
| AU2013202731B2 | Australia | B2 | |
| AU2011257980B2 | Australia | B2 | |
| AU2016234953A1 | Australia | A1 | |
| US9469664B2 | United States of America | B2 | |
| TW201712023A | Taiwan Province of China | A | |
| US2017198287A1 | United States of America | A1 | |
| CN107353317A | China | A | |
| IL243467A | Israel | A | |
| JP2018002728A | Japan | A | |
| KR101829644B1 | Republic of Korea | B1 | |
| KR20180019751A | Republic of Korea | A | |
| TWI616454B | Taiwan Province of China | B | |
| TWI620756B | Taiwan Province of China | B | |
| AU2016234953B2 | Australia | B2 | |
| US10202602B2 | United States of America | B2 | |
| KR101981705B1 | Republic of Korea | B1 | |
| KR20190057160A | Republic of Korea | A | |
| CN103003288B | China | B | |
| US2019218551A1 | United States of America | A1 | |
| JP6634424B2 | Japan | B2 | |
| JP2020018299A | Japan | A | |
| IL223298A | Israel | A | |
| IL223298BThis record | Israel | B | |
| NZ744038A | New Zealand | A | |
| IL272656D0 | Israel | D0 | |
| KR102095478B1 | Republic of Korea | B1 | |
| KR20200036041A | Republic of Korea | A | |
| US10760078B2 | United States of America | B2 | |
| KR102182663B1 | Republic of Korea | B1 | |
| KR20200133284A | Republic of Korea | A | |
| JP2021048886A | Japan | A | |
| US2021139897A1 | United States of America | A1 | |
| IL272656A | Israel | A | |
| IL272656B | Israel | B | |
| IL284154A | Israel | A | |
| IL284154D0 | Israel | D0 | |
| BR112012031363A2 | Brazil | A2 | |
| NZ761522A | New Zealand | A | |
| JP7008056B2 | Japan | B2 | |
| CA2799501C | Canada | C |
6 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 223298
- Application
- 223298
Titles2
- English
- Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups, compositions comprising the same and uses thereof
- Hebrew
- אנאלוגים של אוליגונוקליאוטידים המכילים קשרים בין–תת–יחידיים ו/או קבוצות טרמינליות, תכשירים המכילים אותם ושימושים בהם
Classification
- CPC, 33
- C07H21/02
- C07H21/00
- A61K31/496
- C12N15/113
- C07H1/00
- C07F9/65583
- C07F9/6561
- C07F9/65846
- C07F9/59
- C07F9/572
- A61K31/5377
- C07D265/30
- C07D295/108
- A61P13/12
- A61P21/00
- A61P21/02
- A61P21/04
- A61P25/00
- A61P29/00
- A61P31/04
- A61P31/12
- A61P31/16
- Y02P20/55
- C07F9/22
- C07F9/24
- C07F9/222
- C07F9/26
- C07F9/60
- C07F9/6544
- C12N15/1131
- C12N2310/11
- C12N2310/3233
- C12N2310/3513